Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Lundbeck
Explore 22 clinical trials worldwide
Search
Showing 1-22 of 22 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Lundbeck
Clinical Trials (22)
NCT07035197
Facilitators and Barriers to Eptinezumab Administration in Thailand
N/A
Recruiting
30 participants
Started: Aug 25, 2025 · Completed: Jul 31, 2027
3 conditions
2 sponsors
1 location
NCT06604520
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
PHASE2
Recruiting
50 participants
Started: Mar 20, 2025 · Completed: Sep 1, 2029
6 conditions
3 sponsors
1 location
NCT06701526
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
PHASE4
Recruiting
150 participants
Started: Dec 18, 2024 · Completed: Jun 5, 2026
1 condition
1 sponsor
22 locations
NCT06706622
A Trial of Lu AF82422 in Participants With Multiple System Atrophy (MSA)
PHASE3
Recruiting
360 participants
Started: Dec 3, 2024 · Completed: Oct 25, 2029
1 condition
1 sponsor
66 locations
NCT06428838
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
PHASE3
Not yet recruiting
102 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2025
2 conditions
5 sponsors
2 locations
NCT06557850
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
PHASE1
Recruiting
19 participants
Started: Sep 19, 2024 · Completed: Sep 29, 2026
1 condition
1 sponsor
6 locations
NCT06471829
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
PHASE2
Recruiting
18 participants
Started: Jun 19, 2024 · Completed: Nov 30, 2027
1 condition
1 sponsor
22 locations
NCT06323928
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
PHASE2
Recruiting
845 participants
Started: Apr 1, 2024 · Completed: Apr 30, 2026
1 condition
1 sponsor
119 locations
NCT06312410
The VIA Family 2.0 - a Family Based Intervention for Families with Parental Mental Illness
NA
Recruiting
1,452 participants
Started: Mar 18, 2024 · Completed: Dec 31, 2028
5 conditions
8 sponsors
1 location
NCT06356376
The Effects of Pain and Pain Relief on Peripheral Nerve Excitability
N/A
Recruiting
30 participants
Started: Dec 20, 2023 · Completed: Apr 30, 2024
1 condition
2 sponsors
1 location
NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
PHASE3
Recruiting
315 participants
Started: Jun 8, 2023 · Completed: Aug 31, 2027
1 condition
1 sponsor
63 locations
NCT05669950
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
PHASE1/PHASE2
Recruiting
42 participants
Started: Dec 19, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
7 locations
NCT05355831
Patient-tailored Transcranial Direct Current Stimulation to Improve Stroke Rehabilitation
NA
Recruiting
22 participants
Started: Aug 28, 2022 · Completed: Dec 31, 2024
2 conditions
5 sponsors
3 locations
NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
PHASE3
Recruiting
600 participants
Started: Dec 1, 2021 · Completed: Apr 30, 2028
1 condition
1 sponsor
61 locations
NCT05104476
A Study of Lu AF82422 in Participants With Multiple System Atrophy
PHASE2
Active, not recruiting
64 participants
Started: Nov 16, 2021 · Completed: Mar 7, 2028
1 condition
1 sponsor
19 locations
NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
PHASE3
Recruiting
285 participants
Started: Jun 30, 2021 · Completed: Oct 31, 2026
1 condition
1 sponsor
82 locations
NCT05616559
Precision Medicine in the Depression Treatment
N/A
Recruiting
800 participants
Started: Jun 15, 2021 · Completed: Dec 31, 2026
5 conditions
4 sponsors
1 location
NCT04789915
Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis
PHASE1
Recruiting
46 participants
Started: May 26, 2021 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
NCT04336228
The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
PHASE4
Active, not recruiting
46 participants
Started: Apr 1, 2020 · Completed: Dec 31, 2027
2 conditions
3 sponsors
1 location
NCT04291859
Lu AF28996 in Participants With Parkinson's Disease (PD)
PHASE1
Active, not recruiting
57 participants
Started: Feb 26, 2020 · Completed: Feb 4, 2026
1 condition
1 sponsor
15 locations
NCT03490565
PREoperativ Study of Exercise Training
NA
Active, not recruiting
310 participants
Started: Aug 16, 2018 · Completed: Dec 31, 2028
1 condition
4 sponsors
1 location
NCT03238326
Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
PHASE3
Active, not recruiting
295 participants
Started: Aug 23, 2017 · Completed: Aug 5, 2025
1 condition
2 sponsors
57 locations